Dr. Sarah Elizabeth Norris, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 181-235-3951 |
Drew T Carlton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-9515 Fax: 812-353-9275 |
Dr. Robert L Goddard Jr., MD Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 817 W Rosewood Dr, Bloomington, IN 47404 Phone: 812-929-2952 |
Debbie J Hall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-9515 Fax: 812-353-9275 |
News Archive
Out-of-towners using marijuana in Colorado - which has legally allowed sales of the drug in retail dispensaries since 2014 - are ending up in the emergency room at an increasing rate, reports a new study from Northwestern Medicine and the University of Colorado School of Medicine.
CHX Technologies Inc., a private Canadian pharmaceutical company that is developing new treatments for the prevention of dental diseases, today announced successful results in its final controlled pivotal trial of Prevora, its proprietary antibacterial tooth coating for the prevention of cavities. The trial surpassed objectives set by the Food and Drug Administration (FDA) protocol, clearing the way for CHX to start the process of seeking FDA approval for use in the United States.
Sen. Joe Lieberman, I-Conn., says he'll filibuster Senate Majority Leader Harry Reid's health care reform bill. Politico reports: "Lieberman, who caucuses with Democrats and is positioning himself as a fiscal hawk on the issue, said he opposes any health care bill that includes a government-run insurance program — even if it includes a provision allowing states to opt out of the program, as Reid has said the Senate bill will."
FDA and Congress "should protect physicians' and patients' right" to use FDA-approved drugs for off-label uses "and for the first time allow drugmakers to promote off-label uses that prove beneficial," Richard Epstein, a law professor at the University of Chicago and a senior fellow at the Hoover Institution, writes in a Wall Street Journal opinion piece. He continues, "Right now these drugs provide immense lifesaving opportunities for many sick patients, particularly those threatened by cancer."
› Verified 4 days ago